ConductScience.org, home

Paper42288694

Hepatitis B virus-induced hepatocellular carcinoma: HBx-associated epigenetic mechanisms and therapeutic opportunities.

Husein A and 7 others. Cancer Gene Ther, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Hepatitis B virus-induced hepatocellular carcinoma: HBx-associated epigenetic mechanisms and therapeutic opportunities. Papers, record 42288694. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42288694

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hepatitis B virus-induced hepatocellular carcinoma: HBx-associated epigenetic mechanisms and therapeutic opportunities.
PubMed
Journal
Cancer Gene Ther
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-05
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Husein AAtahar
2Jamal AAzfarhttps://orcid.org/0000-0002-4671-4995
3Kamal MAMohammad Azhar
4Alqurashi YEYaser E
5Al-Malki ESEsam S
6Naiyer MMMohammed M
7Hussain SASyed Arif
8Warsi MKMohiuddin Khan

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
Epigenesis, GeneticMajor topic
Hepatitis B virusMajor topic
Trans-ActivatorsMajor topic
Hepatitis B, ChronicMajor topic
Humans
Viral Regulatory and Accessory Proteins
Animals

Source PubMed

Download CSV of topics

References149

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129249332Nuclear Long Noncoding RNAs: Key Regulators of Gene Expression.Trends Genet2018https://conductscience.org/library/papers/29249332PubMed
226160429Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin.Mol Oncol2015https://conductscience.org/library/papers/26160429PubMed
335629368Integrated Analysis of the Altered lncRNA, microRNA, and mRNA Expression in HBV-Positive Hepatocellular Carcinoma.Life (Basel)2022https://conductscience.org/library/papers/35629368PubMed
419812400MicroRNA expression, survival, and response to interferon in liver cancer.N Engl J Med2009https://conductscience.org/library/papers/19812400PubMed
522820290MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis.J Clin Invest2012https://conductscience.org/library/papers/22820290PubMed
638818956Etiologically Significant microRNAs in Hepatitis B Virus-Induced Hepatocellular Carcinoma.OMICS2024https://conductscience.org/library/papers/38818956PubMed
723437062Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma.PLoS One2013https://conductscience.org/library/papers/23437062PubMed
821145824Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis.J Hepatol2011https://conductscience.org/library/papers/21145824PubMed
932295598The role of long noncoding RNAs in hepatocellular carcinoma.Mol Cancer2020https://conductscience.org/library/papers/32295598PubMed
1039868653Epigenetic Modifications in HBV-Related Hepatocellular Carcinoma.J Viral Hepat2025https://conductscience.org/library/papers/39868653PubMed
1134452630DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application.Clin Epigenetics2021https://conductscience.org/library/papers/34452630PubMed
1222770212Cancer epigenetics: from mechanism to therapy.Cell2012https://conductscience.org/library/papers/22770212PubMed
1323671639Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1.PLoS One2013https://conductscience.org/library/papers/23671639PubMed
1432450266Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential.Antiviral Res2020https://conductscience.org/library/papers/32450266PubMed
1533134907Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg.JHEP Rep2020https://conductscience.org/library/papers/33134907PubMed
1627894309Analysis of long noncoding RNA expression in hepatocellular carcinoma of different viral etiology.J Transl Med2016https://conductscience.org/library/papers/27894309PubMed
1733573130Hepatitis B Virus DNA Integration and Clonal Expansion of Hepatocytes in the Chronically Infected Liver.Viruses2021https://conductscience.org/library/papers/33573130PubMed
1826983541Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor.Nature2016https://conductscience.org/library/papers/26983541PubMed
1929313530Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers.Cell Res2018https://conductscience.org/library/papers/29313530PubMed
2031954490Epidemiology and surveillance for hepatocellular carcinoma: New trends.J Hepatol2020https://conductscience.org/library/papers/31954490PubMed

See all 149 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42288694

GET https://conductscience.org/api/papers/v1/42288694/references?page=2